Today's Analyst Stock Ratings | Upgrades, Downgrades

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD84,046.54+0.44%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

							Get Alert
Sep 28, 2026	MANHManhattan Associates	$204.89	2.49%	Clark WrightDA Davidson 71%	210 210	Previous Buy Current Neutral	Get Alert
Sep 8, 2026	MANHManhattan Associates	$204.89	16.65%	Guy HardwickBarclays 73%	201 239	Previous Overweight Current Overweight	Get Alert
Aug 26, 2026	MANHManhattan Associates	$204.89	26.9%	Joe VruwinkBaird 63%	218 260	Previous Outperform Current Outperform	Get Alert
Jul 29, 2026	MANHManhattan Associates	$204.89	4.93%	Mark SchappelLoop Capital 61%	150 215	Previous Hold Current Buy	Get Alert
Jul 29, 2026	MANHManhattan Associates	$204.89	9.82%	Parker LaneStifel 46%	200 225	Previous Buy Current Buy	Get Alert
Jul 29, 2026	MANHManhattan Associates	$204.89	2.49%	Clark WrightDA Davidson 71%	200 210	Previous Buy Current Buy	Get Alert
Jul 29, 2026	MANHManhattan Associates	$204.89	6.4%	Joe VruwinkBaird 63%	186 218	Previous Outperform Current Outperform	Get Alert
Jul 21, 2026	MANHManhattan Associates	$204.89	-5.8%	George KurosawaCitigroup 51%	177 193	Previous Buy Current Buy	Get Alert
May 29, 2026	MANHManhattan Associates	$204.89	-1.9%	Guy HardwickBarclays 73%	201 239	Previous Overweight Current Overweight	Get Alert
May 20, 2026	MANHManhattan Associates	$204.89	-2.39%	Clark WrightDA Davidson 71%	200 200	Previous Buy Current Buy	Get Alert
Apr 23, 2026	MANHManhattan Associates	$204.89	16.65%	Guy HardwickBarclays 73%	236 239	Previous Overweight Current Overweight	Get Alert
Apr 22, 2026	MANHManhattan Associates	$204.89	-13.61%	George KurosawaCitigroup 51%	177 208	Previous Buy Current Buy	Get Alert
Apr 22, 2026	MANHManhattan Associates	$204.89	-9.22%	Joe VruwinkBaird 63%	183 186	Previous Outperform Current Outperform	Get Alert
Apr 22, 2026	MANHManhattan Associates	$204.89	-2.39%	Parker LaneStifel 46%	200 225	Previous Buy Current Buy	Get Alert
Apr 22, 2026	MANHManhattan Associates	$204.89	-2.39%	Clark WrightDA Davidson 71%	200 240	Previous Buy Current Buy	Get Alert
Mar 16, 2026	MANHManhattan Associates	$204.89	15.18%	Guy HardwickBarclays 73%	236 237	Previous Overweight Current Overweight	Get Alert
Jan 28, 2026	MANHManhattan Associates	$204.89	17.14%	Clark WrightDA Davidson 71%	240 250	Previous Buy Current Buy	Get Alert
Jan 23, 2026	MANHManhattan Associates	$204.89	9.82%	Parker LaneStifel 46%	225 240	Previous Buy Current Buy	Get Alert
Jan 15, 2026	MANHManhattan Associates	$204.89	1.52%	George KurosawaCitigroup 51%	200 208	Previous Neutral Current Buy	Get Alert
Jan 12, 2026	MANHManhattan Associates	$204.89	15.67%	Guy HardwickBarclays 73%	237 239	Previous Overweight Current Overweight	Get Alert
Jan 5, 2026	MANHManhattan Associates	$204.89	-19.47%	Chris QuinteroMorgan Stanley 29%	165 200	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 5, 2026	MANHManhattan Associates	$204.89	17.14%	Terry TillmanTruist Securities 58%	230 240	Previous Buy Current Buy	Get Alert
Dec 23, 2025	MANHManhattan Associates	$204.89	-2.39%	George KurosawaCitigroup 51%	200 204	Previous Neutral Current Neutral	Get Alert
Nov 13, 2025	MANHManhattan Associates	$204.89	16.65%	Guy HardwickBarclays 73%	239 244	Previous Overweight Current Overweight	Get Alert
Oct 22, 2025	MANHManhattan Associates	$204.89	-2.39%	Chris QuinteroMorgan Stanley 29%	195 200	Previous Underweight Current Equal-Weight	Get Alert
Oct 22, 2025	MANHManhattan Associates	$204.89	19.09%	Guy HardwickBarclays 73%	244 247	Previous Overweight Current Overweight	Get Alert
Oct 22, 2025	MANHManhattan Associates	$204.89	17.14%	Brian PetersonRaymond James 68%	240 250	Previous Outperform Current Outperform	Get Alert
Oct 22, 2025	MANHManhattan Associates	$204.89	17.14%	Parker LaneStifel 46%	240 250	Previous Buy Current Buy	Get Alert
Oct 14, 2025	MANHManhattan Associates	$204.89	-4.83%	Chris QuinteroMorgan Stanley 29%	195 205	Previous Underweight Current Underweight	Get Alert
Oct 8, 2025	MANHManhattan Associates	$204.89	22.02%	Parker LaneStifel 46%	250	Previous Initiates Current Buy	Get Alert
Oct 8, 2025	MANHManhattan Associates	$204.89	20.55%	Guy HardwickBarclays 73%	247	Previous Initiates Current Overweight	Get Alert
Jul 23, 2025	MANHManhattan Associates	$204.89	22.02%	Brian PetersonRaymond James 68%	195 250	Previous Outperform Current Outperform	Get Alert
Jul 23, 2025	MANHManhattan Associates	$204.89	2.49%	Mark SchappelLoop Capital 61%	200 210	Previous Hold Current Hold	Get Alert
Jul 23, 2025	MANHManhattan Associates	$204.89	22.02%	Gil LuriaDA Davidson 66%	225 250	Previous Buy Current Buy	Get Alert
Jul 23, 2025	MANHManhattan Associates	$204.89	12.26%	Terry TillmanTruist Securities 58%	210 230	Previous Buy Current Buy	Get Alert
Jul 22, 2025	MANHManhattan Associates	$204.89	-2.39%	Mark SchappelLoop Capital 61%	170 200	Previous Hold Current Hold	Get Alert
Jul 16, 2025	MANHManhattan Associates	$204.89	-2.39%	George KurosawaCitigroup 51%	177 200	Previous Neutral Current Neutral	Get Alert
Jul 16, 2025	MANHManhattan Associates	$204.89	12.26%	Joe VruwinkBaird 63%	212 230	Previous Outperform Current Outperform	Get Alert
Jul 14, 2025	MANHManhattan Associates	$204.89	-7.27%	—	190	Previous Initiates Current Underweight	Get Alert
Jun 10, 2025	MANHManhattan Associates	$204.89	-2.39%	Lachlan BrownRedburn Atlantic 49%	200 270	Previous Buy Current Neutral	Get Alert
May 22, 2025	MANHManhattan Associates	$204.89	2.49%	Terry TillmanTruist Securities 58%	190 210	Previous Buy Current Buy	Get Alert
May 21, 2025	MANHManhattan Associates	$204.89	9.82%	Gil LuriaDA Davidson 66%	200 225	Previous Buy Current Buy	Get Alert
May 21, 2025	MANHManhattan Associates	$204.89	3.47%	Joe VruwinkBaird 63%	197 212	Previous Outperform Current Outperform	Get Alert
Apr 23, 2025	MANHManhattan Associates	$204.89	-7.27%	Terry TillmanTruist Securities 58%	180 190	Previous Buy Current Buy	Get Alert
Apr 23, 2025	MANHManhattan Associates	$204.89	-2.39%	Gil LuriaDA Davidson 66%	195 200	Previous Buy Current Buy	Get Alert
Apr 14, 2025	MANHManhattan Associates	$204.89	-4.83%	Gil LuriaDA Davidson 66%	195 270	Previous Buy Current Buy	Get Alert
Apr 14, 2025	MANHManhattan Associates	$204.89	-9.71%	Terry TillmanTruist Securities 58%	185 285	Previous Buy Current Buy	Get Alert
Apr 10, 2025	MANHManhattan Associates	$204.89	-17.03%	Mark SchappelLoop Capital 61%	170 275	Previous Buy Current Hold	Get Alert
Apr 8, 2025	MANHManhattan Associates	$204.89	-3.85%	Joe VruwinkBaird 63%	197 225	Previous Outperform Current Outperform	Get Alert
Mar 18, 2025	MANHManhattan Associates	$204.89	9.82%	Joe VruwinkBaird 63%	225 282	Previous Outperform Current Outperform	Get Alert
Mar 14, 2025	MANHManhattan Associates	$204.89	-10.2%	George KurosawaCitigroup 51%	184 244	Previous Neutral Current Neutral	Get Alert
Mar 14, 2025	MANHManhattan Associates	$204.89	-2.39%	Quinton GabrielliPiper Sandler 10%	200 268	Previous Overweight Current Overweight	Get Alert
Feb 13, 2025	MANHManhattan Associates	$204.89	—	Dylan BeckerWilliam Blair 23%	—	Previous Market Perform Current Outperform	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	37.63%	Joe VruwinkBaird 63%	282 302	Previous Outperform Current Outperform	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	34.22%	Mark SchappelLoop Capital 61%	275 310	Previous Buy Current Buy	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	31.78%	Gil LuriaDA Davidson 66%	270 315	Previous Buy Current Buy	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	31.78%	Brian PetersonRaymond James 68%	270 305	Previous Outperform Current Outperform	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	30.8%	Quinton GabrielliPiper Sandler 10%	268 326	Previous Overweight Current Overweight	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	39.1%	Terry TillmanTruist Securities 58%	285 310	Previous Buy Current Buy	Get Alert
Jan 29, 2025	MANHManhattan Associates	$204.89	19.09%	George KurosawaCitigroup 51%	244 303	Previous Neutral Current Neutral	Get Alert
Jan 27, 2025	MANHManhattan Associates	$204.89	47.88%	George KurosawaCitigroup 51%	303 306	Previous Neutral Current Neutral	Get Alert
Dec 16, 2024	MANHManhattan Associates	$204.89	49.35%	George KurosawaCitigroup 51%	287 306	Previous Neutral Current Neutral	Get Alert
Nov 25, 2024	MANHManhattan Associates	$204.89	59.11%	Quinton GabrielliPiper Sandler 10%	326	Previous Initiates Current Overweight	Get Alert
Oct 23, 2024	MANHManhattan Associates	$204.89	53.74%	Gil LuriaDA Davidson 66%	285 315	Previous Buy Current Buy	Get Alert
Oct 23, 2024	MANHManhattan Associates	$204.89	48.86%	Brian PetersonRaymond James 68%	255 305	Previous Outperform Current Outperform	Get Alert
Oct 22, 2024	MANHManhattan Associates	$204.89	48.37%	Joe VruwinkBaird 63%	263 304	Previous Outperform Current Outperform	Get Alert
Oct 11, 2024	MANHManhattan Associates	$204.89	51.3%	Terry TillmanTruist Securities 58%	275 310	Previous Buy Current Buy	Get Alert
Sep 25, 2024	MANHManhattan Associates	$204.89	40.08%	George KurosawaCitigroup 51%	257 287	Previous Neutral Current Neutral	Get Alert
Sep 16, 2024	MANHManhattan Associates	$204.89	39.1%	Mark SchappelLoop Capital 61%	265 285	Previous Buy Current Buy	Get Alert
Jul 24, 2024	MANHManhattan Associates	$204.89	29.34%	Mark SchappelLoop Capital 61%	250 265	Previous Buy Current Buy	Get Alert
Jul 24, 2024	MANHManhattan Associates	$204.89	39.1%	Gil LuriaDA Davidson 66%	260 285	Previous Buy Current Buy	Get Alert
Jun 28, 2024	MANHManhattan Associates	$204.89	25.43%	George KurosawaCitigroup 51%	220 257	Previous Neutral Current Neutral	Get Alert
May 16, 2024	MANHManhattan Associates	$204.89	26.9%	Gil LuriaDA Davidson 66%	240 260	Previous Buy Current Buy	Get Alert
May 14, 2024	MANHManhattan Associates	$204.89	26.9%	Lachlan BrownRedburn Atlantic 49%	260	Previous Initiates Current Buy	Get Alert
Apr 25, 2024	MANHManhattan Associates	$204.89	17.14%	Gil LuriaDA Davidson 66%	220 240	Previous Neutral Current Buy	Get Alert
Apr 24, 2024	MANHManhattan Associates	$204.89	7.37%	George KurosawaCitigroup 51%	220 260	Previous Neutral Current Neutral	Get Alert
Apr 24, 2024	MANHManhattan Associates	$204.89	9.82%	Blair AbernethyRosenblatt 76%	225 225	Previous Neutral Current Neutral	Get Alert
Apr 15, 2024	MANHManhattan Associates	$204.89	9.82%	Blair AbernethyRosenblatt 76%	225 225	Previous Neutral Current Neutral	Get Alert
Mar 13, 2024	MANHManhattan Associates	$204.89	26.9%	George KurosawaCitigroup 51%	260	Previous Initiates Current Neutral	Get Alert
Jan 31, 2024	MANHManhattan Associates	$204.89	9.82%	Blair AbernethyRosenblatt 76%	215 225	Previous Neutral Current Neutral	Get Alert
Jan 31, 2024	MANHManhattan Associates	$204.89	22.02%	Brian PetersonRaymond James 68%	214 250	Previous Outperform Current Outperform	Get Alert
Jan 31, 2024	MANHManhattan Associates	$204.89	26.9%	Terry TillmanTruist Securities 58%	240 260	Previous Buy Current Buy	Get Alert
Jan 23, 2024	MANHManhattan Associates	$204.89	4.93%	Blair AbernethyRosenblatt 76%	200 215	Previous Neutral Current Neutral	Get Alert
Oct 25, 2023	MANHManhattan Associates	$204.89	-2.39%	Blair AbernethyRosenblatt 76%	196 200	Previous Neutral Current Neutral	Get Alert
Oct 19, 2023	MANHManhattan Associates	$204.89	-4.34%	Blair AbernethyRosenblatt 76%	196	Previous Neutral Current Neutral	Get Alert
Sep 14, 2023	MANHManhattan Associates	$204.89	12.26%	Mark SchappelLoop Capital 61%	220 230	Previous Buy Current Buy	Get Alert
Jul 26, 2023	MANHManhattan Associates	$204.89	12.26%	Terry TillmanTruist Securities 58%	210 230	Previous Buy Current Buy	Get Alert
Jul 26, 2023	MANHManhattan Associates	$204.89	4.45%	Brian PetersonRaymond James 68%	165 214	Previous Outperform Current Outperform	Get Alert
Jul 26, 2023	MANHManhattan Associates	$204.89	-4.34%	Blair AbernethyRosenblatt 76%	160 196	Previous Neutral Current Neutral	Get Alert
May 24, 2023	MANHManhattan Associates	$204.89	0.05%	Mark SchappelLoop Capital 61%	190 205	Previous Current Buy	Get Alert
Apr 26, 2023	MANHManhattan Associates	$204.89	-7.27%	Mark SchappelLoop Capital 61%	190	Previous Current Buy	Get Alert
Apr 26, 2023	MANHManhattan Associates	$204.89	-10.2%	Joe VruwinkBaird 63%	168 184	Previous Current Outperform	Get Alert
Apr 26, 2023	MANHManhattan Associates	$204.89	2.49%	Terry TillmanTruist Securities 58%	205 210	Previous Current Buy	Get Alert
Apr 26, 2023	MANHManhattan Associates	$204.89	-21.91%	Blair AbernethyRosenblatt 76%	150 160	Previous Current Neutral	Get Alert
Apr 11, 2023	MANHManhattan Associates	$204.89	-26.79%	Blair AbernethyRosenblatt 76%	150	Previous Buy Current Neutral	Get Alert
Feb 22, 2023	MANHManhattan Associates	$204.89	-29.23%	Gil LuriaDA Davidson 66%	145	Previous Initiates Current Neutral	Get Alert
Feb 3, 2023	MANHManhattan Associates	$204.89	-26.79%	Blair AbernethyRosenblatt 76%	140 150	Previous Current Buy	Get Alert
Jul 27, 2022	MANHManhattan Associates	$204.89	-19.47%	Brian PetersonRaymond James 68%	165 170	Previous Current Outperform	Get Alert
Jul 22, 2022	MANHManhattan Associates	$204.89	-26.79%	Blair AbernethyRosenblatt 76%	150 165	Previous Current Buy	Get Alert
Mar 22, 2022	MANHManhattan Associates	$204.89	-17.03%	Brian PetersonRaymond James 68%	170	Previous Market Perform Current Outperform	Get Alert

Recent Analyst Stock Rating News

PRO

William Blair Downgrades Alignment Healthcare to Market Perform

William Blair analyst Ryan Daniels downgrades Alignment Healthcare (NASDAQ:ALHC) from Outperform to Market Perform.

PRO

UBS Upgrades ArcelorMittal to Buy

UBS analyst Andrew Jones upgrades ArcelorMittal (NYSE:MT) from Neutral to Buy.

PRO

Citigroup Maintains Buy on Sunrun, Lowers Price Target to $14

Citigroup analyst Vikram Bagri maintains Sunrun (NASDAQ:RUN) with a Buy and lowers the price target from $16 to $14.

PRO

Citigroup Maintains Buy on Viper Energy, Lowers Price Target to $52

Citigroup analyst Paul Diamond maintains Viper Energy (NASDAQ:VNOM) with a Buy and lowers the price target from $57 to $52.

PRO

Citigroup Maintains Neutral on PepsiCo, Lowers Price Target to $135

Citigroup analyst Filippo Falorni maintains PepsiCo (NASDAQ:PEP) with a Neutral and lowers the price target from $142 to $135.

PRO

Citigroup Maintains Buy on Kodiak Gas Services, Lowers Price Target to $82

Citigroup analyst Douglas Irwin maintains Kodiak Gas Services (NYSE:KGS) with a Buy and lowers the price target from $86 to $82.

PRO

Citigroup Downgrades Pershing Square to Sell, Maintains Price Target to $45

Citigroup analyst Matthew Heimermann downgrades Pershing Square (NYSE:PS) from Neutral to Sell and maintains the price target from $45 to $45.

PRO

Citigroup Initiates Coverage On Fortune Brands with Buy Rating, Announces Price Target of $48

Citigroup analyst Anthony Pettinari initiates coverage on Fortune Brands (NYSE:FBIN) with a Buy rating and announces Price Target of $48.

PRO

Maxim Group Initiates Coverage On The RMR Group with Buy Rating, Announces Price Target of $26

Maxim Group analyst Michael Diana initiates coverage on The RMR Group (NASDAQ:RMR) with a Buy rating and announces Price Target of $26.

PRO

JP Morgan Maintains Neutral on Steel Dynamics, Lowers Price Target to $260

JP Morgan analyst Bill Peterson maintains Steel Dynamics (NASDAQ:STLD) with a Neutral and lowers the price target from $272 to $260.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website